AsherBio
Drug Discovery
AsherBio valuation and funding history | Last updated: April 16, 2024 | 2 funding rounds
Current Valuation
N/A
As of April 16, 2024
Total Funding Raised
N/A
Across 2 rounds
Last Round
Later Stage VC (Series C)
$55.0M
Last Funding
Apr 2024
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| April 16, 2024 | Later Stage VC (Series C) | $55.0M | N/A | - |
| September 1, 2021 | Early Stage VC (Series B) | $108.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
AsherBio is currently valued at N/A as of April 16, 2024.
What is AsherBio Worth in 2026?
AsherBio is a leading private company in the Drug Discovery sector. Track AsherBio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How AsherBio Valuation is Determined
Private company valuations like AsherBio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.